Patient-Reported Outcomes with Consolidation Durvalumab Versus Placebo Following Concurrent Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer: Results from the Phase 3 ADRIATIC Trial.


Novello S., Cheng Y., Spigel D., Fang J., Chen Y., Zenke Y., ...Daha Fazla

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, cilt.21, sa.6, 2026 (SCI-Expanded, Scopus)